Loading…
Saved in:
Source: | Molecular Cancer, Vol 23, Iss 1, Pp 1-20 (2024) |
---|---|
Publisher Information: | BMC, 2024. |
Publication Year: | 2024 |
Subject Terms: |
PD1/PD-L1 inhibitors, ccRCC, Tumor Immune evasion, Combination therapy, Biomarkers, Neoplasms. Tumors. Oncology. Including cancer and carcin
|
Description: |
Abstract The advent of PD1/PD-L1 inhibitors has significantly transformed the therapeutic landscape for clear cell renal cell carcinoma (ccR
|
Database: | Directory of Open Access Journals |